to test the dopamine hypothesis of schizophrenia the authors measured specific 3h-neuroleptic/dopamine binding sites in three dopamin-rich regions of 59 postmortem normal human brains and 50 postmortem brains from schizophrenic patients using 3h-haloperidol and 3h-spiperone .
C0040615
neuroleptic
C0018546
haloperidol